These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 4525537)

  • 1. Systemic lysostaphin in man--apparent antimicrobial activity in a neutropenic patient.
    Stark FR; Thornsvard C; Flannery EP; Artenstein MS
    N Engl J Med; 1974 Aug; 291(5):239-40. PubMed ID: 4525537
    [No Abstract]   [Full Text] [Related]  

  • 2. Lysostaphin treatment of methicillin-resistant Staphylococcus aureus keratitis in the rabbit.
    Dajcs JJ; Hume EB; Moreau JM; Caballero AR; Cannon BM; O'Callaghan RJ
    Invest Ophthalmol Vis Sci; 2000 May; 41(6):1432-7. PubMed ID: 10798659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lysostaphin in treatment of neonatal Staphylococcus aureus infection.
    Oluola O; Kong L; Fein M; Weisman LE
    Antimicrob Agents Chemother; 2007 Jun; 51(6):2198-200. PubMed ID: 17420212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methicillin-resistant Staphylococcus aureus. Antimicrobial susceptibility.
    Benner EJ; Morthland V
    N Engl J Med; 1967 Sep; 277(13):678-80. PubMed ID: 5182623
    [No Abstract]   [Full Text] [Related]  

  • 5. Methicillin resistance in Staphylococcus epidermidis epidemiologic studies.
    Bentley DW
    Contrib Microbiol Immunol; 1973; 1():650-8. PubMed ID: 4805328
    [No Abstract]   [Full Text] [Related]  

  • 6. [Comparative study of the sensitivity to different antibiotics of Staphylococci isolated from patients and attendants].
    Sobolev VR; Vlasova IV; Solov'eva VE; Bogdanova LF
    Antibiotiki; 1971 Feb; 16(2):162-7. PubMed ID: 4934037
    [No Abstract]   [Full Text] [Related]  

  • 7. In vivo efficacy of the antimicrobial peptide ranalexin in combination with the endopeptidase lysostaphin against wound and systemic meticillin-resistant Staphylococcus aureus (MRSA) infections.
    Desbois AP; Gemmell CG; Coote PJ
    Int J Antimicrob Agents; 2010 Jun; 35(6):559-65. PubMed ID: 20206480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial sensitivity patterns in Staphylococcus aureus from animals.
    Biberstein EL; Franti CE; Jang SS; Ruby A
    J Am Vet Med Assoc; 1974 Jun; 164(12):1183-6. PubMed ID: 4495045
    [No Abstract]   [Full Text] [Related]  

  • 9. Perspective. Hospital-acquired infections: the problems of methicillin-resistant Staphylococcus aureus and infections with Klebsiella pneumoniae.
    Finland M
    Am J Med Sci; 1972 Sep; 264(3):207-11. PubMed ID: 4486504
    [No Abstract]   [Full Text] [Related]  

  • 10. Lysostaphin.
    Koening MG
    J Infect Dis; 1969 Jan; 119(1):101-2. PubMed ID: 5191239
    [No Abstract]   [Full Text] [Related]  

  • 11. New trends in the chemotherapy of staphylococcal infections.
    Russo G; Tempera G; Stefani S; Nicoletti G
    Chemioterapia; 1986 Apr; 5(2):116-9. PubMed ID: 3635440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lysostaphin as a treatment for systemic Staphylococcus aureus infection in a mouse model.
    Kokai-Kun JF; Chanturiya T; Mond JJ
    J Antimicrob Chemother; 2007 Nov; 60(5):1051-9. PubMed ID: 17848374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mixed infection with methicilin-resistant and methicillin-sensitive Staphylococcus aureus of phage type 88.
    Annear DI
    Med J Aust; 1971 May; 1(22):1167-8. PubMed ID: 4254076
    [No Abstract]   [Full Text] [Related]  

  • 14. Two heterogeneously vancomycin-intermediate clinical isolates of methicillin-sensitive and methicillin-resistant Staphylococcus aureus in a Turkish university hospital: brief report of a surveillance study.
    Torun MM; Bahar H; Demirci M; Altaş K; Bağdatli Y; Kocazeybek B; Kapi M; Hiramatsu K
    Int J Antimicrob Agents; 2005 Dec; 26(6):508-10. PubMed ID: 16256313
    [No Abstract]   [Full Text] [Related]  

  • 15. [Demethyl-vancomycin in treatment of resistant staphylococcal infections. A clinical evaluation].
    Zhu F
    Zhonghua Yi Xue Za Zhi; 1992 Sep; 72(9):562-4, 575. PubMed ID: 1338524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparative evaluation of the effect of lincomycin, novobiocin, methicillin and oxacillin on staphylococci isolated in the neurosurgical clinic].
    Imshenetskaia VF
    Antibiotiki; 1970 Apr; 15(4):341-5. PubMed ID: 5203497
    [No Abstract]   [Full Text] [Related]  

  • 17. Activity of several antibiotics against staphylococci.
    Aceti A; Attanasio R
    Microbiologica; 1988 Apr; 11(2):159-63. PubMed ID: 3405098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical implications of methicillin-resistance in Staphylococcus aureus.
    Harris DM
    Guys Hosp Rep; 1970; 119(2):145-54. PubMed ID: 5202526
    [No Abstract]   [Full Text] [Related]  

  • 19. Microbiological indications for the treatment of Staphylococcus aureus infections.
    Fabbri A; Tacchella A; Belli ML; Losurdo G
    Chemioterapia; 1988 Dec; 7(6):378-81. PubMed ID: 3219748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Validity of the measurement of sensitivity of Staphylococcus aureus with heterogeneous resistance to methicillin, oxacillin, cephalothin and cephaloridine].
    Yourassowsky E; Schoutens E; Vanderlinden MP; Prudhomme MR; Van Audenarde M
    Acta Clin Belg Suppl; 1971; 7():45-56. PubMed ID: 5292119
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.